A recent case report published in SAGE Open Medical Case Reports reveals that breast cancer surgery may inadvertently trigger metastasis, highlighting the urgent need for treatments targeting cancer stem cells. The study notes that cancer relapse often occurs within 18 months post-surgery. While most recurrences appear in superficial tissue, they can also develop in the deep tissue of the reconstructed breast. Researchers suggest that the inflammatory response to surgical wounds may stimulate the proliferation of cancer cells, leading to metastasis.

The persistence of cancer cells post-treatment, including surgery and chemotherapy or radiotherapy, remains an issue, as these conventional treatments do not target cancer stem cells. These cells are particularly dangerous due to their ability to resist chemotherapy and regenerate new tumor cells. Therefore, finding treatments that effectively target cancer stem cells is crucial to prevent relapse.

The Beljanski Foundation, a nonprofit dedicated to holistic cancer research, has funded studies on natural compounds like Pao pereira and Rauwolfia vomitoria, which show promise in destroying both primary cancer cells and cancer stem cells. This research has demonstrated success in mice with pancreatic and ovarian cancers, indicating the potential of these compounds in broader cancer treatment.

To support this groundbreaking research, The Beljanski Foundation will host the second Beljanski Integrative Cancer Conference from April 25-27, 2025, in Austin, TX. This conference is designed for cancer patients, caregivers, healthcare professionals, coaches and anyone passionate about preventing or healing cancer through functional, natural and integrative medicine. Attendees will have the opportunity to learn from experts in the field, gain insights into the latest cancer prevention and treatment strategies and connect with a community dedicated to holistic cancer care.